{
    "timestamp": "Apr 29, 2025 7:50 AM EST",
    "stats": {
        "input_words": 1479825,
        "output_words": 1838,
        "filings_processed": 24
    },
    "filings": [
        {
            "company_name": "Regeneron Pharmaceuticals",
            "stock": "REGN",
            "wiki_url": "https://en.wikipedia.org/wiki/Regeneron_Pharmaceuticals",
            "change_percent": 0,
            "price": 611.36,
            "filing_type": "10-Q",
            "filing_time": "2025-04-29T06:51:48-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/872589/000180422025000022/0001804220-25-000022-index.htm",
            "accession_number": "0001804220-25-000022",
            "summary_points": [
                "1. Regeneron's Q1 2025 net income increased by $86.7 million compared to Q1 2024, despite a 39% decline in EYLEA U.S. net product sales due to biosimilar competition.",
                "2.  Regeneron's contingent reimbursement obligation to Sanofi totaled $1.453 billion as of March 31, 2025, with only 20% of quarterly collaboration profits applied towards repayment.",
                "3.  Biocon's launch of an aflibercept biosimilar has been delayed until the second half of 2026 due to settled litigation with Regeneron."
            ]
        },
        {
            "company_name": "NXP Semiconductors",
            "stock": "NXPI",
            "wiki_url": "https://en.wikipedia.org/wiki/NXP_Semiconductors",
            "change_percent": 0,
            "price": 196.49,
            "filing_type": "10-Q",
            "filing_time": "2025-04-29T06:13:52-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1413447/000141344725000031/0001413447-25-000031-index.htm",
            "accession_number": "0001413447-25-000031",
            "summary_points": [
                "1. NXP's Q1 2025 revenue decreased by 9.3% year-over-year to $2.8 billion.",
                "2. NXP plans to complete three acquisitions (Aviva Links, TTTech Auto, and Kinara, Inc.) totaling $1,174.5 million in 2025.",
                "3.  NXP's adoption of new accounting standards (ASU 2023-09 and evaluation of ASU 2024-03) may impact future financial reporting starting in 2027."
            ]
        },
        {
            "company_name": "Brown & Brown",
            "stock": "BRO",
            "wiki_url": "https://en.wikipedia.org/wiki/Brown_%26_Brown",
            "change_percent": 0,
            "price": 114.87,
            "filing_type": "10-Q",
            "filing_time": "2025-04-28T17:06:06-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/79282/000095017025059393/0000950170-25-059393-index.htm",
            "accession_number": "0000950170-25-059393",
            "summary_points": [
                "1. Brown & Brown, Inc.'s Q1 2025 net income increased 13% year-over-year to $331 million.",
                "2.  The company has significantly increased its debt, reaching $3,806 million by March 31, 2025, a $225 million increase from the previous quarter.",
                "3. Brown & Brown, Inc. anticipates a total of $865 million in intangible asset amortization expense from 2025 to 2029 and is facing numerous legal proceedings with potentially material impacts on its financials."
            ]
        },
        {
            "company_name": "Incyte",
            "stock": "INCY",
            "wiki_url": "https://en.wikipedia.org/wiki/Incyte",
            "change_percent": 0,
            "price": 59.46,
            "filing_type": "8-K",
            "filing_time": "2025-04-29T07:03:53-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/879169/000087916925000053/0000879169-25-000053-index.htm",
            "accession_number": "0000879169-25-000053",
            "summary_points": [
                "1. Incyte Corporation's total revenues for the first fiscal quarter ended March 31, 2025, were $1,053 million, a 20% year-over-year increase.",
                "2. Jakafi\u00ae net product revenues increased 24% year-over-year to $709 million in Q1 2025, driven by increased paid demand, the Inflation Reduction Act's Part D redesign, and less de-stocking than in Q1 2024.",
                "3. Incyte plans to initiate Phase 3 studies for its CDK2 inhibitor (INCB123667) in ovarian cancer in 2025 and anticipates Phase 3 data for tafasitamab in the second half of 2025."
            ]
        },
        {
            "company_name": "Xylem Inc.",
            "stock": "XYL",
            "wiki_url": "https://en.wikipedia.org/wiki/Xylem_Inc.",
            "change_percent": 0,
            "price": 115.82,
            "filing_type": "8-K",
            "filing_time": "2025-04-29T07:03:45-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1524472/000152447225000019/0001524472-25-000019-index.htm",
            "accession_number": "0001524472-25-000019",
            "summary_points": [
                "1. Xylem Inc. reported first-quarter 2025 revenue of $2.1 billion, a 2% increase on a reported basis and a 3% increase organically, as of April 29, 2025.",
                "2.  Adjusted earnings per share for Q1 2025 were $1.03, a 14% year-over-year increase compared to Q1 2024.",
                "3. Xylem Inc. reaffirmed its full-year 2025 adjusted earnings per share guidance of $4.50 to $4.70, as of April 29, 2025, despite current market volatility."
            ]
        },
        {
            "company_name": "American Tower",
            "stock": "AMT",
            "wiki_url": "https://en.wikipedia.org/wiki/American_Tower",
            "change_percent": 0,
            "price": 211.02,
            "filing_type": "8-K",
            "filing_time": "2025-04-29T07:03:45-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1053507/000105350725000100/0001053507-25-000100-index.htm",
            "accession_number": "0001053507-25-000100",
            "summary_points": [
                "1. American Tower Corporation's net income decreased by 45.9% to $499 million in Q1 2025, primarily due to foreign currency losses of approximately $(345.7) million compared to foreign currency gains of approximately $127.7 million in Q1 2024, and a gain on the sale of South Africa Fiber.",
                "2.  Despite the significant net income decrease, Adjusted EBITDA increased by 1.9% to $1,744 million in Q1 2025.",
                "3.  American Tower projects total property revenue for the full year 2025 to be between $9,970 million and $10,120 million, a midpoint growth rate of 1.1% compared to the prior year,  with the midpoint growth rate for AFFO attributable to AMT common stockholders, as adjusted, of 5.0%."
            ]
        },
        {
            "company_name": "Altria",
            "stock": "MO",
            "wiki_url": "https://en.wikipedia.org/wiki/Altria",
            "change_percent": 0,
            "price": 58.19,
            "filing_type": "8-K",
            "filing_time": "2025-04-29T07:03:23-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/764180/000076418025000047/0000764180-25-000047-index.htm",
            "accession_number": "0000764180-25-000047",
            "summary_points": [
                "1. Altria Group, Inc. reported a 5.7% decrease in net revenues for the first quarter of 2025, primarily due to lower net revenues in the smokeable products segment, compared to the same period in 2024.",
                "2.  Despite a 47.9% decrease in reported diluted EPS to $0.63, adjusted diluted EPS increased by 6.0% to $1.23 for the first quarter of 2025 compared to the same period in 2024.",
                "3. The company reaffirms its full-year 2025 adjusted diluted EPS growth rate guidance of 2% to 5% versus 2024, resulting in an expected range of $5.30 to $5.45, but this is contingent on various factors including the economy, consumer behavior, illicit product enforcement, and regulatory developments."
            ]
        },
        {
            "company_name": "Kraft Heinz",
            "stock": "KHC",
            "wiki_url": "https://en.wikipedia.org/wiki/Kraft_Heinz",
            "change_percent": 0,
            "price": 28.78,
            "filing_type": "8-K",
            "filing_time": "2025-04-29T07:02:50-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1637459/000163745925000059/0001637459-25-000059-index.htm",
            "accession_number": "0001637459-25-000059",
            "summary_points": [
                "1. Kraft Heinz's Q1 2025 net sales decreased by 6.4% year-over-year to $6.0 billion, primarily due to a 5.6 percentage point decline in volume/mix, partially offset by a 0.9 percentage point increase in price.",
                "2.  Kraft Heinz lowered its full-year 2025 outlook, now expecting organic net sales to be down 1.5% to 3.5% and constant currency adjusted operating income to be down 5% to 10%, as of April 29, 2025.",
                "3. The company anticipates an approximate $0.23 headwind to its full-year 2025 adjusted EPS due to several countries enacting global minimum tax regulations, partially offset by benefits from a 2024 corporate restructuring."
            ]
        },
        {
            "company_name": "PayPal",
            "stock": "PYPL",
            "wiki_url": "https://en.wikipedia.org/wiki/PayPal",
            "change_percent": 0,
            "price": 64.91,
            "filing_type": "8-K",
            "filing_time": "2025-04-29T07:01:41-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1633917/000163391725000062/0001633917-25-000062-index.htm",
            "accession_number": "0001633917-25-000062",
            "summary_points": [
                "1. As of April 29, 2025, PayPal Holdings, Inc. reported a 3% year-over-year increase in total payment volume to $417.2 billion, despite a 7% decrease in payment transactions.",
                "2.  PayPal's GAAP operating income increased by 31% year-over-year to $1.5 billion in the quarter ending March 31, 2025, while non-GAAP operating income rose by 16% to $1.6 billion.",
                "3.  Despite a strong first quarter, PayPal maintained its full-year guidance for 2025 due to uncertainty in the global macroeconomic environment."
            ]
        },
        {
            "company_name": "Coca-Cola Company (The)",
            "stock": "KO",
            "wiki_url": "https://en.wikipedia.org/wiki/The_Coca-Cola_Company",
            "change_percent": 0,
            "price": 71.73,
            "filing_type": "8-K",
            "filing_time": "2025-04-29T06:58:41-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/21344/000002134425000024/0000021344-25-000024-index.htm",
            "accession_number": "0000021344-25-000024",
            "summary_points": [
                "1. Coca-Cola's net revenues declined 2% year-over-year to $11.1 billion in Q1 2025, despite 6% organic revenue growth.",
                "2.  While Q1 2025 operating income surged 71%, this was significantly inflated by accounting adjustments;  currency-neutral operating income only grew 10%.",
                "3. Coca-Cola projects 5-6% organic revenue growth for 2025, but anticipates significant currency headwinds impacting net revenue (2-3%) and EPS (5-6%)."
            ]
        },
        {
            "company_name": "A. O. Smith",
            "stock": "AOS",
            "wiki_url": "https://en.wikipedia.org/wiki/A._O._Smith",
            "change_percent": 0,
            "price": 64.79,
            "filing_type": "8-K",
            "filing_time": "2025-04-29T06:55:54-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/91142/000009114225000073/0000091142-25-000073-index.htm",
            "accession_number": "0000091142-25-000073",
            "summary_points": [
                "1. A. O. Smith Corporation reported first-quarter 2025 sales of $964 million, a 2% decrease year-over-year, primarily due to lower water heater volumes in North America and China.",
                "2.  Diluted earnings per share decreased by 5% year-over-year to $0.95 in the first quarter of 2025.",
                "3. The company maintained its full-year 2025 outlook of flat to up 2% consolidated sales and diluted EPS in a range of $3.60 to $3.90, despite uncertainty surrounding tariffs."
            ]
        },
        {
            "company_name": "LabCorp",
            "stock": "LH",
            "wiki_url": "https://en.wikipedia.org/wiki/Labcorp",
            "change_percent": 0,
            "price": 230.13,
            "filing_type": "8-K",
            "filing_time": "2025-04-29T06:53:52-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/920148/000092014825000054/0000920148-25-000054-index.htm",
            "accession_number": "0000920148-25-000054",
            "summary_points": [
                "1. Labcorp's Q1 2025 revenue increased to $3.35 billion from $3.18 billion in Q1 2024, a 5.3% increase, but diluted EPS decreased to $2.52 from $2.69.",
                "2.  As of March 31, 2025, Labcorp held $0.37 billion in cash and cash equivalents and $5.57 billion in total debt.",
                "3. Labcorp reaffirmed its 2025 revenue and free cash flow guidance (6.7% to 8.0% revenue growth and $1.10 billion to $1.25 billion in free cash flow), but raised the midpoint of its adjusted EPS guidance by $0.05 to a range of $15.70 to $16.40."
            ]
        },
        {
            "company_name": "Regeneron Pharmaceuticals",
            "stock": "REGN",
            "wiki_url": "https://en.wikipedia.org/wiki/Regeneron_Pharmaceuticals",
            "change_percent": 0,
            "price": 611.36,
            "filing_type": "8-K",
            "filing_time": "2025-04-29T06:37:44-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/872589/000180422025000020/0001804220-25-000020-index.htm",
            "accession_number": "0001804220-25-000020",
            "summary_points": [
                "1. Regeneron Pharmaceuticals, Inc. reported first-quarter 2025 revenues of $3.0 billion, a 4% decrease year-over-year, with GAAP diluted EPS of $7.27 and non-GAAP diluted EPS of $8.22.",
                "2.  EYLEA HD U.S. net sales increased by 54% year-over-year to $307 million in Q1 2025, while total U.S. EYLEA HD and EYLEA net sales decreased by 26% year-over-year to $1.04 billion.",
                "3. The FDA issued a Complete Response Letter (CRL) on April 23, 2025, for Regeneron's EYLEA HD pre-filled syringe submission, delaying its launch;  the FDA also rejected an application for extended dosing intervals for EYLEA HD, citing insufficient data."
            ]
        },
        {
            "company_name": "Royal Caribbean Group",
            "stock": "RCL",
            "wiki_url": "https://en.wikipedia.org/wiki/Royal_Caribbean_Group",
            "change_percent": 0,
            "price": 216.49,
            "filing_type": "8-K",
            "filing_time": "2025-04-29T06:31:39-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/884887/000088488725000093/0000884887-25-000093-index.htm",
            "accession_number": "0000884887-25-000093",
            "summary_points": [
                "1. Royal Caribbean Cruises Ltd. reported Q1 2025 EPS of $2.70 and adjusted EPS of $2.71, exceeding company guidance due to stronger-than-expected pricing and lower costs (as of April 29, 2025).",
                "2.  Compared to Q1 2024, Q1 2025 saw a 100% increase in Net Income ($0.7 billion vs. $0.4 billion), a 40% increase in Adjusted Net Income ($0.7 billion vs. $0.5 billion), a 9% increase in guests served (2.2 million vs. 2.05 million), and a 13.9% increase in as-reported Gross Margin Yields.",
                "3. Royal Caribbean Group increased its full-year 2025 adjusted EPS guidance to $14.55-$15.55, representing approximately 28% year-over-year growth (as of April 29, 2025)."
            ]
        },
        {
            "company_name": "United Parcel Service",
            "stock": "UPS",
            "wiki_url": "https://en.wikipedia.org/wiki/United_Parcel_Service",
            "change_percent": 0,
            "price": 97.08,
            "filing_type": "8-K",
            "filing_time": "2025-04-29T06:09:54-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1090727/000109072725000046/0001090727-25-000046-index.htm",
            "accession_number": "0001090727-25-000046",
            "summary_points": [
                "1. UPS's consolidated revenues decreased by 0.7% year-over-year in the first quarter of 2025, totaling $21.5 billion compared to $21.7 billion in Q1 2024.",
                "2.  Despite the revenue decline, consolidated operating profit increased by 3.3% year-over-year to $1.7 billion in Q1 2025.",
                "3.  Due to macroeconomic uncertainty, UPS is not providing an updated full-year outlook as of April 29, 2025."
            ]
        },
        {
            "company_name": "Honeywell",
            "stock": "HON",
            "wiki_url": "https://en.wikipedia.org/wiki/Honeywell",
            "change_percent": 0,
            "price": 200.57,
            "filing_type": "8-K",
            "filing_time": "2025-04-29T06:05:55-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/773840/000077384025000035/0000773840-25-000035-index.htm",
            "accession_number": "0000773840-25-000035",
            "summary_points": [
                "1. Honeywell International Inc. exceeded its first-quarter 2025 guidance on all metrics, reporting 8% year-over-year sales growth and 4% organic sales growth.",
                "2.  Despite macroeconomic uncertainty, Honeywell maintained its full-year organic growth guidance (2-5%) and raised its adjusted earnings per share guidance to $10.20-$10.50 (up 5 cents at the midpoint from prior guidance).",
                "3. Honeywell plans to separate its Automation and Aerospace businesses, and spin off its Advanced Materials business, resulting in three publicly-listed companies by the second half of 2026."
            ]
        },
        {
            "company_name": "Hilton Worldwide",
            "stock": "HLT",
            "wiki_url": "https://en.wikipedia.org/wiki/Hilton_Worldwide",
            "change_percent": 0,
            "price": 221.6,
            "filing_type": "8-K",
            "filing_time": "2025-04-29T06:02:11-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1585689/000158568925000086/0001585689-25-000086-index.htm",
            "accession_number": "0001585689-25-000086",
            "summary_points": [
                "1. Hilton's Q1 2025 diluted EPS increased by 18% year-over-year, reaching $1.23.",
                "2. Hilton's development pipeline expanded by 7% year-over-year to 503,400 rooms as of March 31, 2025.",
                "3. Hilton projects full-year 2025 adjusted EBITDA to be between $3,650 million and $3,710 million."
            ]
        },
        {
            "company_name": "News Corp (Class B)",
            "stock": "NWS",
            "wiki_url": "https://en.wikipedia.org/wiki/News_Corp",
            "change_percent": 0,
            "price": 31.26,
            "filing_type": "8-K",
            "filing_time": "2025-04-28T18:30:49-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1564708/000156470825000231/0001564708-25-000231-index.htm",
            "accession_number": "0001564708-25-000231",
            "summary_points": [
                "1. As of April 28, 2025, News Corp had repurchased approximately US$666,231,474.49 worth of Class A and Class B shares under its US$1 billion stock repurchase program.",
                "2. On April 28, 2025, News Corp repurchased 21,663,857 Class A shares and 10,692,689 Class B shares.",
                "3. News Corp's stock repurchase program, announced previously, is ongoing and intends to repurchase up to US$1 billion of Class A and Class B common stock, subject to market conditions and other factors."
            ]
        },
        {
            "company_name": "Ameren",
            "stock": "AEE",
            "wiki_url": "https://en.wikipedia.org/wiki/Ameren",
            "change_percent": 0,
            "price": 98.86,
            "filing_type": "8-K",
            "filing_time": "2025-04-28T17:25:46-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1002910/000110465925040304/0001104659-25-040304-index.htm",
            "accession_number": "0001104659-25-040304",
            "summary_points": [
                "1. Noelle K. Eder resigned from the Ameren Corporation Board of Directors on April 22, 2025, effective May 6, 2025, due to relocation outside the United States.",
                "2.  The filing is an 8-K current report, indicating a significant event requiring immediate disclosure to the SEC.",
                "3. The resignation of Noelle K. Eder doesn't appear to present any immediate financial or operational risks to the company."
            ]
        },
        {
            "company_name": "Interpublic Group of Companies (The)",
            "stock": "IPG",
            "wiki_url": "https://en.wikipedia.org/wiki/The_Interpublic_Group_of_Companies",
            "change_percent": 0,
            "price": 24.8,
            "filing_type": "8-K",
            "filing_time": "2025-04-28T17:25:15-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/51644/000005164425000042/0000051644-25-000042-index.htm",
            "accession_number": "0000051644-25-000042",
            "summary_points": [
                "1. IPG's organic net revenue decreased by 3.6% in Q1 2025,  a result aligning with prior predictions but exacerbated by significant account losses.",
                "2. IPG's Q1 2025 adjusted diluted EPS remained flat year-over-year at $0.33.",
                "3. IPG anticipates $300 to $350 million in restructuring charges in 2025, with equivalent annual cost savings expected for the merged Omnicom entity beginning in 2026."
            ]
        },
        {
            "company_name": "Waste Management",
            "stock": "WM",
            "wiki_url": "https://en.wikipedia.org/wiki/Waste_Management,_Inc.",
            "change_percent": 0,
            "price": 228.96,
            "filing_type": "8-K",
            "filing_time": "2025-04-28T17:11:15-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/823768/000110465925040282/0001104659-25-040282-index.htm",
            "accession_number": "0001104659-25-040282",
            "summary_points": [
                "1. Waste Management Inc. reported first-quarter 2025 revenue of $6,018 million, a 16.7% year-over-year increase, driven primarily by a 6.5% core price increase and 4.0% Collection and Disposal yield.",
                "2. Adjusted operating EBITDA for the WM Legacy Business grew 6.0% year-over-year to $1,593 million, with a margin of 30% for the fourth consecutive quarter.",
                "3. WM Healthcare Solutions contributed $95 million in adjusted operating EBITDA in the first quarter of 2025, and the company expects to achieve $80 to $100 million in synergies in 2025 from the Stericycle acquisition."
            ]
        },
        {
            "company_name": "Constellation Brands",
            "stock": "STZ",
            "wiki_url": "https://en.wikipedia.org/wiki/Constellation_Brands",
            "change_percent": 0,
            "price": 185.92,
            "filing_type": "8-K",
            "filing_time": "2025-04-28T17:08:58-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/16918/000119312525100820/0001193125-25-100820-index.htm",
            "accession_number": "0001193125-25-100820",
            "summary_points": [
                "1. Constellation Brands, Inc. amended and restated its Tenth Amended and Restated Credit Agreement, refinancing $2.25 billion in commitments and extending the maturity date to April 28, 2030.",
                "2. The general liens basket under the amended credit agreement increased from 7.5% to 10.0% of consolidated tangible assets.",
                "3.  As of April 28, 2025, Constellation Brands and its subsidiaries had existing financial relationships with certain Credit Agreement Lenders and their affiliates, including services for which customary fees are paid and derivative arrangements."
            ]
        },
        {
            "company_name": "Brown & Brown",
            "stock": "BRO",
            "wiki_url": "https://en.wikipedia.org/wiki/Brown_%26_Brown",
            "change_percent": 0,
            "price": 114.87,
            "filing_type": "8-K",
            "filing_time": "2025-04-28T17:03:47-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/79282/000095017025059389/0000950170-25-059389-index.htm",
            "accession_number": "0000950170-25-059389",
            "summary_points": [
                "1. Brown & Brown, Inc. reported total revenues of $1.4 billion for the first quarter of 2025, an 11.6% increase year-over-year.",
                "2. Diluted net income per share increased to $1.15 in Q1 2025, a 12.7% year-over-year rise, while adjusted diluted net income per share reached $1.29, a 13.2% increase.",
                "3. The company declared a regular quarterly cash dividend of $0.15 per share, payable on May 21, 2025, to shareholders of record on May 12, 2025."
            ]
        },
        {
            "company_name": "Nucor",
            "stock": "NUE",
            "wiki_url": "https://en.wikipedia.org/wiki/Nucor",
            "change_percent": 0,
            "price": 116.65,
            "filing_type": "8-K",
            "filing_time": "2025-04-28T17:00:40-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/73309/000119312525100774/0001193125-25-100774-index.htm",
            "accession_number": "0001193125-25-100774",
            "summary_points": [
                "1. Nucor's first-quarter 2025 net earnings decreased 81% year-over-year, from $845 million to $156 million.",
                "2. This decrease was attributed to lower average selling prices and reduced steel mill volumes.",
                "3. Nucor anticipates higher second-quarter 2025 earnings compared to the first quarter, driven by increased prices and volumes in certain segments."
            ]
        }
    ]
}